Compare SHW & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHW | GRDN |
|---|---|---|
| Founded | 1866 | 2004 |
| Country | United States | United States |
| Employees | N/A | 3600 |
| Industry | RETAIL: Building Materials | Retail-Drug Stores and Proprietary Stores |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.7B | 2.3B |
| IPO Year | 1994 | N/A |
| Metric | SHW | GRDN |
|---|---|---|
| Price | $315.57 | $34.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $385.50 | $37.33 |
| AVG Volume (30 Days) | ★ 1.5M | 429.6K |
| Earning Date | 04-28-2026 | 03-11-2026 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.26 | N/A |
| Revenue | ★ $17,900,800,000.00 | N/A |
| Revenue This Year | $5.26 | N/A |
| Revenue Next Year | $4.57 | $7.14 |
| P/E Ratio | ★ $31.20 | $117.77 |
| Revenue Growth | ★ 2.09 | N/A |
| 52 Week Low | $301.58 | $19.17 |
| 52 Week High | $379.65 | $38.12 |
| Indicator | SHW | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 38.50 | 52.24 |
| Support Level | $301.58 | $27.73 |
| Resistance Level | $347.50 | $36.13 |
| Average True Range (ATR) | 7.88 | 1.88 |
| MACD | 0.41 | 0.11 |
| Stochastic Oscillator | 38.64 | 49.68 |
Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 4,800 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.